Medical Devices Europe

Europe Left Atrial Appendage Closure Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Europe Left Atrial Appendage Closure Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $362.0 Mn Placeholder estimate
Estimate 2025 $414.1 Mn 19.2% of the global market
Projected 2034 $1.39 Bn 235.6% Adds $975.6 Mn over 9 forecast years
CAGR 2025–2034 14.4% Faster than 89% of 173 Medical Devices markets here
Key players 5
  • Europe is 19.23% of the global market.
  • Among regions, the largest is North America at $1.08 Bn.
  • Fastest growing: Africa at 17.9% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$975.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Left Atrial Appendage Closure Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $362.0 Mn — —
2025 (base) $414.1 Mn +$52.1 Mn —
2026 (forecast) $473.7 Mn +$59.6 Mn +14.4%
2027 (forecast) $541.9 Mn +$68.2 Mn +30.9%
2028 (forecast) $620.0 Mn +$78.0 Mn +49.7%
2029 (forecast) $709.2 Mn +$89.3 Mn +71.3%
2030 (forecast) $811.4 Mn +$102.1 Mn +95.9%
2031 (forecast) $928.2 Mn +$116.8 Mn +124.2%
2032 (forecast) $1.06 Bn +$133.7 Mn +156.4%
2033 (forecast) $1.21 Bn +$152.9 Mn +193.4%
2034 (forecast) $1.39 Bn +$174.9 Mn +235.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Left Atrial Appendage Closure Market Analysis at a glance
Market size, 2025$414.1 Mn placeholder estimate
Forecast, 2034$1.39 Bn placeholder estimate
Growth (CAGR), 2025–203414.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, setting and end user (see all)
Key playersBoston Scientific Corporation, Abbott Laboratories, AtriCure, Inc, Conformal Medical, Lifetech Scientific (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Left Atrial Appendage Closure Market Analysis Executive Summary

Left atrial appendage closure devices seal off a small pouch in the heart to lower stroke risk in people with atrial fibrillation.

Key segments of the left Atrial Appendage Closure market include product (Endocardial Devices and Epicardial Devices) and setting (Hospitals and Cardiac Centers).

Bar chart: Europe Left Atrial Appendage Closure market size, 2024–2034, placeholder estimates. $362.0 Mn in 2024, $414.1 Mn in 2025 and $1.39 Bn in 2034, 14.4% CAGR.
Europe Left Atrial Appendage Closure market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Left Atrial Appendage Closure Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the left Atrial Appendage Closure market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the left Atrial Appendage Closure market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the left Atrial Appendage Closure market.

Competitive Landscape for Left Atrial Appendage Closure Market in Europe

The left Atrial Appendage Closure market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Left Atrial Appendage Closure Market in Europe

Left Atrial Appendage Closure in Europe: rules and payment

In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.⁠[1] In the countries we cover here, medical devices are regulated by ANSM (France)⁠[2], BfArM (Germany)⁠[3], Ministry of Health (Italy)⁠[4], Roszdravnadzor (Russia)⁠[5], AEMPS (Spain)⁠[6] and MHRA (UK)⁠[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[8]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how left Atrial Appendage Closure products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Left Atrial Appendage Closure right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Left Atrial Appendage Closure in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Left Atrial Appendage Closure market in Europe?
Placeholder estimate: about $414.1 Mn in 2025, rising to about $1.39 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Left Atrial Appendage Closure market in Europe growing?
Placeholder estimate: about 14.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Left Atrial Appendage Closure market report cover?
The report splits the market by product (Endocardial Devices, Epicardial Devices), setting (Hospitals, Cardiac Centers) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Left Atrial Appendage Closure market?
Key players include Boston Scientific Corporation, Abbott Laboratories, AtriCure, Inc, Conformal Medical and Lifetech Scientific.
What is driving the Left Atrial Appendage Closure market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the left Atrial Appendage Closure market.
Who regulates Left Atrial Appendage Closure in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How much research is published on Left Atrial Appendage Closure?
PubMed lists 1,353 papers on Left Atrial Appendage Closure added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Europe

See all

Related on cardiovascular and stroke

See the topic